107
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Selecting the optimal targeted therapy for relapsed B-acute lymphoblastic leukemia

ORCID Icon, , , & ORCID Icon
Pages 2271-2273 | Received 03 Jan 2020, Accepted 19 Apr 2020, Published online: 19 May 2020
 

Author contributions

JF wrote the manuscript. EL reported the PET CTs, prepared the images for and edited the manuscript. GC, CB and MS reviewed and edited the manuscript.

Disclosure statement

JF, EL, and MS have declared potential conflicts of interest. GC and CB have no potential conflicts of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.